While cannabis is federally legal in Canada for medicinal purposes, several of the largest banks have avoided the sector, allowing Alterna Savings to become one of the early leaders...
The New West Summit, which will move to a larger venue in Oakland after two initial events in San Francisco, has rapidly established itself as a leading venue for cannabis...
Horizons Medical Marijuana Life Sciences ETF (TSX: HMMJ) (OTC: HMLSF), the world’s first and still only cannabis ETF, has adjusted its portfolio this month as its benchmark, the North...
MedReleaf Reports First Quarter Fiscal 2018 Results Cannabis oil extracts drive sequential improvement in average selling price, adjusted product contribution margin, and Adjusted EBITDA MARKHAM, ON, Aug. 14, 2017...
In contrast to a period when promotion and fluff have grabbed the attention of novice stock investors interested in the legal cannabis theme since early 2013, we are now seeing companies...
Horizons Marijuana Life Sciences Index ETF (TSX: HMMJ) (OTC: HMLSF) has been hit hard over the past two weeks, declining 8.4% since July 26th despite what has been a stable market...
After a big 2nd half of 2016 and some strength in early 2017, Canadian LPs were under heavy pressure from April through June following a glut of supply (new...
MedReleaf Corp. Announces Distribution Agreement with CannaKorp Inc. First Licenced Producer to bring innovative vaporizing technology to Canada MARKHAM, ON, July 17, 2017 /PRNewswire/ – MedReleaf Corp. (TSX: LEAF)...
Canada’s medical cannabis market began as a flower-only market, but, following a court ruling, the licensed producers (LPs) were permitted to begin producing extracts in late 2015. While these products...
MedReleaf Reports Fourth Quarter and Fiscal Year 2017 Results Fiscal 2017 Adjusted EBITDA of $14 million on $40 million in sales; phase 1 Bradford Facility expansion complete and in...
Earlier this month, Tilray made a big change in how it will be marketing its medical cannabis products. Historically, it was selling its dried cannabis products under common strain names,...
In what appears to be one of the most successful cannabis industry investments to date, MedMen Opportunity Fund achieved realized and unrealized gains of about C$33.5mm on a C$10mm investment...
The Canadian cannabis sector’s largest IPO to date is a dud. The $100mm MedReleaf (TSX: LEAF) IPO was priced at $9.50 but opened for trading at $7.51 before trading...
After initially filing its preliminary prospectus in April, ACMPR licensed producer MedReleaf (TSX: LEAF) has filed the final prospectus for its $100.7mm initial public offering and secondary offering, selling shares...
After filing its preliminary prospectus for its pending IPO last month, MedReleaf revised it on May 9th, sharing a lot more information. The Canadian cannabis deal, underwritten by GMP...
While Health Canada, which provided an update on April 24th, continues to get the official data out to the public very slowly, the patient enrollment growth in the ACMPR...
Ontario-based MedReleaf filed its preliminary prospectus ahead of its planned Initial Public Offering and has engaged GMP Securities to lead the deal. Most of the Canadian licensed producers have gone...
Exclusive Interview with Jason Zandberg of PI Financial With Canada’s Liberal Party prepared to table legislation to legalize cannabis for adult use next week, we checked in with Jason...
Same-day delivery for MedReleaf patients in the Greater Toronto Area: Cannabis dispensaries no longer only option for patients seeking convenient access to medication TORONTO, Feb. 16, 2017 /CNW/ –...
Minister Hehr announces a new reimbursement policy for Cannabis for Medical Purposes VANCOUVER, Nov. 22, 2016 /CNW/ – The Honourable Kent Hehr, Minister of Veterans Affairs and Associate Minister of...
More than six months ago, New Cannabis Ventures warned of pending changes in Canada with respect to medical cannabis reimbursement for Veterans. The Veterans Affairs Canada expenditures have skyrocketed since...
This is a big month for Canada’s federal medical cannabis program, MMPR, as Health Canada must respond to the Allard ruling by August 24th, paving the way for home...
Health Canada, which oversees the Canadian medical cannabis program, MMPR, reported data for the quarter ending 12/31/15 today. The number of patients enrolled in the program grew 29.9% from...
Following a recent public request by their trade association, the CMCIA, to the Canadian government to take action regarding the rapid proliferation of federally illegal cannabis dispensaries, the licensed...
MedReleaf Corp. Becomes the First and Only ISO 9001:2008 Certified Licensed Producer of Medical Cannabis in Canada December 22, 2015 11:05 AM Eastern Standard Time TORONTO–(BUSINESS WIRE)–MedReleaf is now...
